News

Recent data from the Australian Institute of Health and Welfare1 shows a sharp rise in ADHD medication use across the country. In 2023–24, nearly 600,000 Australians were dispensed over 4.6 million prescriptions, up from just 2 per 1,000 people in 2004–05 to 22 per 1,000 today. Psychostimulants like dexamfetamine, methylphenidate, and lisdexamfetamine make up 87% of these prescriptions, with non-stimulant options available for those who need alternatives.

According to a recent SBS News article, there is growing awareness of ADHD in Australia, especially among adults, but there are also significant challenges in getting diagnosed and treated. Despite increased public understanding, the healthcare system is struggling to keep up with demand.

In the 12 months leading up to August 2025, Australians consumed an estimated 22.2 tonnes of methylamphetamine, cocaine, MDMA, and heroin—marking a 34% increase compared to the previous year. This sharp rise highlights growing concerns about illicit drug use and its impact on public health and safety as well as workplace safety.

The Australian Criminal Intelligence Commission’s (ACIC) National Wastewater Drug Monitoring Program Report 23, based on data collected in April and June 2024, provides insights into cannabis consumption patterns across Australia.